Clinical Trials Directory

Trials / Completed

CompletedNCT00691535

Genetics of Symptomatology and Treatment Response in Psychotic Major Depression

Association of BDNF, COMT, MDRI, CRH, CRF, and GC Receptor Genetic Polymorphisms With Symptomatology and Treatment Response in Psychotic Major Depression

Status
Completed
Phase
Study type
Observational
Enrollment
500 (planned)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

We hope to learn more about the biology of psychiatric illness with the hope of improving the diagnosis and treatment of such psychiatric conditions as major depression.

Detailed description

From the blood sample you donate, the researchers will obtain DNA. This DNA will be used to search for DNA markers related to the underlying biology of psychiatric illness and how this might explain the symptoms of these disorders. Research using DNA is an important way to try to understand human disease and/or the role genes play in disease. In effect, part of your blood sample will be used to attempt to understand how genetic factors contribute to the symptoms of such psychiatric conditions as major depression.

Conditions

Timeline

Start date
2003-10-01
Primary completion
2012-06-01
First posted
2008-06-05
Last updated
2019-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00691535. Inclusion in this directory is not an endorsement.

Genetics of Symptomatology and Treatment Response in Psychotic Major Depression (NCT00691535) · Clinical Trials Directory